Tramazoline: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
m (Protected "Tramazoline": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{Drugbox
{{Drugbox
| IUPAC_name       = N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine
| Verifiedfields = changed
| image             = Tramazoline.png
| Watchedfields = changed
| CAS_number        =
| verifiedrevid = 457287903
| ATC_prefix        = R01
| IUPAC_name = ''N''-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1''H''-imidazol-2-amine
| ATC_suffix        = AA09
| image = Tramazoline.png
| PubChem          = 5524
 
| DrugBank          =  
<!--Clinical data-->
| C=13|H=17|N=3
| tradename =
| molecular_weight  = 215.294 g/mol
| Drugs.com = {{drugs.com|international|tramazoline}}
| bioavailability  =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| protein_bound    =
| pregnancy_US = <!-- A / B            / C / D / X -->
| metabolism        =
| pregnancy_category =   
| elimination_half-life =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| excretion        =
| legal_CA = <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
| pregnancy_AU     = <!-- A / B1 / B2 / B3 / C / D / X -->
| legal_UK = <!-- GSL        / P      / POM / CD / Class A, B, C -->
| pregnancy_US     = <!-- A / B            / C / D / X -->
| legal_US = <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| pregnancy_category=   
| legal_status =
| legal_AU         = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| routes_of_administration =
| legal_CA         = <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
 
| legal_UK         = <!-- GSL        / P      / POM / CD / Class A, B, C -->
<!--Pharmacokinetic data-->
| legal_US         = <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| bioavailability = 
| legal_status     =  
| protein_bound = 
| routes_of_administration =  
| metabolism = 
| elimination_half-life = 
| excretion = 
 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 1082-57-1
| ATC_prefix = R01
| ATC_suffix = AA09
| PubChem = 5524
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = SLE31693IV
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 32573
 
<!--Chemical data-->
| C=13 | H=17 | N=3
| molecular_weight = 215.294 g/mol
}}
}}
              __NOTOC__
{{SI}}
{{CMG}}
{{CMG}}
==Overview==




'''Tramazoline''' is a chemical that is used in the form of '''tramazoline hydrochloride''' in nasal decongestant preparations. <ref>{{cite web|first=Boehringer Ingelheim|title=Spray-Tish Consumer Information|url=http://www.mydr.com.au/medicines/cmis/spray-tish-nasal-spray|work=Consumer Medicines Information|publisher=MyDr.com.au|accessdate=16 April 2011}}</ref> It is an α-adrenergic receptor agonist that inhibits secretion of nasal mucus.


'''Tramazoline''' is a nasal preparation.
It causes [[hypertension]].<ref name="pmid7721439">{{cite journal |author=Peng N, Meng QC, King K, Oparil S, Wyss JM |title=Acute hypertension increases norepinephrine release in the anterior hypothalamic area |journal=Hypertension |volume=25 |issue=4 Pt 2 |pages=828–33 |date=April 1995 |pmid=7721439 |doi= 10.1161/01.hyp.25.4.828|url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=7721439}}</ref>
 
 
 
==References==
{{reflist|2}}


{{Nasal preparations}}
{{Nasal preparations}}


[[Category:Imidazolines]]
[[Category:Imidazolines]]
 
[[Category:Drug]]
{{WH}}
{{WS}}

Latest revision as of 17:19, 20 August 2015

Tramazoline
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
UNII
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H17N3
Molar mass215.294 g/mol
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Tramazoline

Articles

Most recent articles on Tramazoline

Most cited articles on Tramazoline

Review articles on Tramazoline

Articles on Tramazoline in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tramazoline

Images of Tramazoline

Photos of Tramazoline

Podcasts & MP3s on Tramazoline

Videos on Tramazoline

Evidence Based Medicine

Cochrane Collaboration on Tramazoline

Bandolier on Tramazoline

TRIP on Tramazoline

Clinical Trials

Ongoing Trials on Tramazoline at Clinical Trials.gov

Trial results on Tramazoline

Clinical Trials on Tramazoline at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tramazoline

NICE Guidance on Tramazoline

NHS PRODIGY Guidance

FDA on Tramazoline

CDC on Tramazoline

Books

Books on Tramazoline

News

Tramazoline in the news

Be alerted to news on Tramazoline

News trends on Tramazoline

Commentary

Blogs on Tramazoline

Definitions

Definitions of Tramazoline

Patient Resources / Community

Patient resources on Tramazoline

Discussion groups on Tramazoline

Patient Handouts on Tramazoline

Directions to Hospitals Treating Tramazoline

Risk calculators and risk factors for Tramazoline

Healthcare Provider Resources

Symptoms of Tramazoline

Causes & Risk Factors for Tramazoline

Diagnostic studies for Tramazoline

Treatment of Tramazoline

Continuing Medical Education (CME)

CME Programs on Tramazoline

International

Tramazoline en Espanol

Tramazoline en Francais

Business

Tramazoline in the Marketplace

Patents on Tramazoline

Experimental / Informatics

List of terms related to Tramazoline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tramazoline is a chemical that is used in the form of tramazoline hydrochloride in nasal decongestant preparations. [1] It is an α-adrenergic receptor agonist that inhibits secretion of nasal mucus.

It causes hypertension.[2]


References

  1. ↑ "Spray-Tish Consumer Information". Consumer Medicines Information. MyDr.com.au. Retrieved 16 April 2011. |first1= missing |last1= in Authors list (help)
  2. ↑ Peng N, Meng QC, King K, Oparil S, Wyss JM (April 1995). "Acute hypertension increases norepinephrine release in the anterior hypothalamic area". Hypertension. 25 (4 Pt 2): 828–33. doi:10.1161/01.hyp.25.4.828. PMID 7721439.
Retrieved from "https://www.wikidoc.org/index.php?title=Tramazoline&oldid=1137734"